Autres langues

23/09 Circio to Cancel Subsequent NOK200 Million Share Offering
21/09 Circio Holding ASA(OB:CRNA) added to S&P Global BMI Index
15/09 Circio Raises NOK200 Million via Private Placement; Subsequent Offering Planned
31/08 Circio Holding ASA Reports Earnings Results for the Half Year Ended June 30, 2026
26/08 Circio Holding, Full Circles Therapeutics Enter Joint Gene Therapy Research Deal
26/08 Circio Holding ASA and Full Circles Therapeutics Inc. Jointly Announce in Vivo Cell Therapy Research
25/08 Circio Holding ASA Announces Board Appointments
06/08 Circio : selected to deliver oral presentation at the prestigious ESGCT annual meeting
28/07 Certain Ordinary Shares of Circio Holding ASA are subject to a Lock-Up Agreement Ending on 28-JUL-2026.
16/07 Circio Holding Signs Protein Secretion Research Collaboration with Avenue Biosciences
16/07 Circio : and Avenue Biosciences jointly announce research collaboration to enhance protein secretion for gene therapy
16/07 Circio Holding ASA And Avenue Biosciences Jointly Announce Research Collaboration To Enhance Protein Secretion For Gene Therapy
24/06 Circio Holding, Tcelltech Collaborate on CAR-T Cell Therapy Research
24/06 Circio Holding ASA and Tcelltech GmbH Jointly Announces CAR-T Cell Therapy Research Collaboration
10/06 Circio Raises NOK300 Million Via Share Placing, Exercise of Warrants
10/06 Circio Raises NOK300 Via Share Placing, Exercise of Warrants
01/06 Circio Holding ASA and GenAssist Ltd Announce Gene Therapy Research Collaboration for Muscle Diseases and in Vivo Cell Therapy
01/06 Circio : and GenAssist jointly announce gene therapy research collaboration for muscle diseases and in vivo cell therapy
01/06 Circio, Genassist jointly announce gene therapy research collaboration
27/05 Circio, AaviGen Team Up on Heart Gene Therapy Research
27/05 Circio and Aavigen to collaborate on in heart gene therapy
27/05 Circio Holding ASA And AaviGen Gmbh Jointly Announce Research Collaboration To Advance Novel Gene Therapies For Heart Diseases
26/05 Circio commences exercise period for warrants
21/05 Circio Holding ASA Files EPO Patent Application Covering Critical Aspects of Its Circvec Platform for Enhanced Gene and Cell Therapy
21/05 Circio Holding files new Circvec patent application
Aucun résultat pour cette recherche